Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery. - Wikidata - wikimedia - TriplyDB

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

http://www.wikidata.org/entity/Q41109836

about

Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.Discovery of novel inhibitors for the treatment of glaucoma.In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device.Topical delivery of aqueous micellar resolvin E1 analog (RX-10045)Advance of the application of nano-controlled release system in ophthalmic drug delivery.Repurposing an orally available drug for the treatment of geographic atrophy.Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters.Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases.Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery.

P2860

Q35565484-4A0B3E22-4137-4BD9-8CDB-6932A663103B Q36108207-880FF2A7-B6C1-4D06-8A86-B890DC0E59FC Q36273801-8CCC46A8-FDE4-434D-B65A-0D63D2B04C1A Q37231179-52E10D94-C44D-4896-B05A-7BC2F04C968E Q38658684-578745F7-FDE4-443F-9533-3B290D6C5A8F Q38775689-E634C99C-EEA4-4BB2-A3C4-B7F67B65C953 Q38840174-E9FF344A-BCCD-48E5-9AD4-A0BAF91FB52E Q39087808-DFD018C6-6B3F-4BB1-BA8A-696A01DB4959 Q40500118-9A4430A0-1913-4E8A-8DDC-C8508AACB63E Q43864907-349E3639-8E85-4758-A8BC-DB4764D00549 Q47164896-6199AF6D-3F28-4292-88E1-E928BB7DA9EA Q50335529-989FE16F-3F83-4B0E-A9DB-429480109658

P2860

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

http://www.wikidata.org/entity/Q41109836

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

@en

type

label

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

@en

prefLabel

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

@en

P1433

Q41109836-3C8F05C3-06BF-42D5-8CF4-58DE9DFF5361

P1476

Q41109836-44D51DC8-B8F2-4A52-9EAB-73D4D5BED18A

P2093

Q41109836-075832FA-39FC-441D-B3D4-445FB8EAE423

Q41109836-2FBF587B-05B7-4DF9-8094-4C71A214CA52

Q41109836-383EE087-BF8E-477D-A913-80185AEB70A4

Q41109836-A7638C1E-C6EB-4010-85E1-5FCAA2608A21

Q41109836-D2BA36BC-6B9D-4C3F-80FC-C36E1ACC48E9

P2860

Q41109836-04EB753F-CB33-4826-AD0D-0128EA6D761A

Q41109836-0CA1439D-EF42-42FE-94C3-0FB881F8FFB3

Q41109836-14416114-AE1A-4C90-8F29-09DA4BB3CF44

Q41109836-170FA378-36CF-4096-95F9-DD7D5D5ED32E

Q41109836-1AF1D23D-6B04-468B-8C31-07DDAC8E1509

Q41109836-1CAFC20C-F27C-484A-9CB9-513EFABE5164

Q41109836-1DE5E4E8-9500-4D3F-994E-6583E573EAA0

Q41109836-238D82F6-ABE4-4FFA-8CA7-211594B5B997

Q41109836-254AE46F-A84F-4C03-866D-662C68BC842B

Q41109836-2C0A8254-307F-4F13-A820-39443C980D3A

P2888

Q41109836-39F38F44-F931-435D-9353-F5FE02D8E121

P304

Q41109836-B399E419-73FE-4617-8321-FFA683409EA4

P31

Q41109836-949DADBA-027D-42CC-B6E2-FA329D18238D

P356

Q41109836-90C35C6C-0481-405A-99BF-188C52AD5A0D

P407

Q41109836-6C499C7A-F358-4369-A97D-7E315B503B52

P433

Q41109836-DBFDB7D2-FB4D-4973-8D23-45C7C88E5B8D

P478

Q41109836-DBE2CAF7-D85A-459D-B4A2-5FD53EFC348D

P577

Q41109836-D749189F-6DFC-4915-90A7-51AFFD42E5A1

P5875

Q41109836-8854C695-4E0D-4861-9D91-1C417A40480A

P6179

Q41109836-E856987E-CCD5-42CB-A934-D651E5B085A1

P698

Q41109836-60FA60E0-5D32-42DB-8123-9FB5BD31AF50

P932

Q41109836-91DAB7D8-40C2-4A67-90B1-4332A731D437

P356

S12249-014-0244-2

P1433

AAPS PharmSciTech

P1476

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

@en

P2093

Ashim K Mitra

http://www.w3.org/2001/XMLSchema#string

Dhananjay Pal

http://www.w3.org/2001/XMLSchema#string

Kishore Cholkar

http://www.w3.org/2001/XMLSchema#string

Ravinder Earla

http://www.w3.org/2001/XMLSchema#string

Sriram Gunda

http://www.w3.org/2001/XMLSchema#string

P2860

His-tagged protein purification by metal-chelate affinity extraction with nickel-chelate reverse micelles.

Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.

Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.

Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.

Photodynamic therapy: a new approach to the treatment of choroidal neovascularization secondary to age-related macular degeneration.

Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis.

Degree, duration, and causes of visual loss in uveitis.

Topical and systemic drug delivery to the posterior segments.

Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

P2888

s12249-014-0244-2

P304

610-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-014-0244-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268876123

http://www.w3.org/2001/XMLSchema#string

P6179

1018900821

http://www.w3.org/2001/XMLSchema#string

P698

25425389

http://www.w3.org/2001/XMLSchema#string

P932

4444623

http://www.w3.org/2001/XMLSchema#string